By month two, something shifted
The pharmacokinetic profile supported once-weekly dosing, with a mean half-life of approximately six days
The most common side effects of Wegovy include nausea, diarrhea, vomiting, constipation, abdominal (stomach) pain, headache, fatigue, dyspepsia (indigestion), dizziness, abdominal distension, eructation (belching), hypoglycemia (low blood sugar) in patients with diabetes, flatulence (gas buildup) and gastroesophageal reflux disease (heartburn)
That said, at commercial scale, recombinant production can offer a major cost advantage over chemical synthesis, which requires expensive protected amino acid building blocks and coupling reagents
This shift helps patients preserve their strength and energy, even as the number on the scale goes down
SHARPIN promotes cell proliferation of cholangiocarcinoma and inhibits ferroptosis via p53/SLC7A11/GPX4 signaling